Analyst and Research & Development Day to be held in New York on November 10 at 8:30 am. Webcast Link
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VAXX:
- Vaxxinity to hold analyst and research and development day
- Vaxxinity to Present at Upcoming Investor Conferences in November
- Vaxxinity completes enrollment in Phase 3 trial of UB-612
- Vaxxinity Announces First Subjects Dosed in Phase 1 Clinical Trial of UB-313 for Preventive Treatment of Migraine
- Vaxxinity announces first subjects dosed in Phase 1 trial of UB-313